GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells

Abstract The single nucleotide polymorphism (SNP) rs9679162 located on GALNT14 gene predicts therapeutic outcomes in patients with intermediate and advanced hepatocellular carcinoma (HCC), but the molecular mechanism remains unclear. Here, the associations between SNP genotypes, GALNT14 expression,...

Full description

Bibliographic Details
Main Authors: Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh
Format: Article
Language:English
Published: Nature Publishing Group 2022-11-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05419-y
_version_ 1811318063428009984
author Yu-De Chu
Tan-Chi Fan
Ming-Wei Lai
Chau-Ting Yeh
author_facet Yu-De Chu
Tan-Chi Fan
Ming-Wei Lai
Chau-Ting Yeh
author_sort Yu-De Chu
collection DOAJ
description Abstract The single nucleotide polymorphism (SNP) rs9679162 located on GALNT14 gene predicts therapeutic outcomes in patients with intermediate and advanced hepatocellular carcinoma (HCC), but the molecular mechanism remains unclear. Here, the associations between SNP genotypes, GALNT14 expression, and downstream molecular events were determined. A higher GALNT14 cancerous/noncancerous ratio was associated with the rs9679162-GG genotype, leading to an unfavorable postoperative prognosis. A novel exon-6-skipped GALNT14 mRNA variant was identified in patients carrying the rs9679162-TT genotype, which was associated with lower GALNT14 expression and favorable prognosis. Cell-based experiments showed that elevated levels of GALNT14 promoted HCC growth, migration, and resistance to anticancer drugs. Using a comparative lectin-capture glycoproteomic approach, PHB2 was identified as a substrate for GALNT14-mediated O-glycosylation. Site-directed mutagenesis experiments revealed that serine-161 (Ser161) was the O-glycosylation site. Further analysis showed that O-glycosylation of PHB2-Ser161 was required for the GALNT14-mediated growth-promoting phenotype. O-glycosylation of PHB2 was positively correlated with GALNT14 expression in HCC, resulting in increased interaction between PHB2 and IGFBP6, which in turn led to the activation of IGF1R-mediated signaling. In conclusion, the GALNT14-rs9679162 genotype was associated with differential expression levels of GALNT14 and the generation of a novel exon-6-skipped GALNT14 mRNA variant, which was associated with a favorable prognosis in HCC. The GALNT14/PHB2/IGF1R cascade modulated the growth, migration, and anticancer drug resistance of HCC cells, thereby opening the possibility of identifying new therapeutic targets against HCC.
first_indexed 2024-04-13T12:19:12Z
format Article
id doaj.art-4fe5349a99bb40d58c95f4bc3674d74c
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-13T12:19:12Z
publishDate 2022-11-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-4fe5349a99bb40d58c95f4bc3674d74c2022-12-22T02:47:16ZengNature Publishing GroupCell Death and Disease2041-48892022-11-01131111310.1038/s41419-022-05419-yGALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cellsYu-De Chu0Tan-Chi Fan1Ming-Wei Lai2Chau-Ting Yeh3Liver Research Center, Chang Gung Memorial HospitalInstitute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at LinkouLiver Research Center, Chang Gung Memorial HospitalLiver Research Center, Chang Gung Memorial HospitalAbstract The single nucleotide polymorphism (SNP) rs9679162 located on GALNT14 gene predicts therapeutic outcomes in patients with intermediate and advanced hepatocellular carcinoma (HCC), but the molecular mechanism remains unclear. Here, the associations between SNP genotypes, GALNT14 expression, and downstream molecular events were determined. A higher GALNT14 cancerous/noncancerous ratio was associated with the rs9679162-GG genotype, leading to an unfavorable postoperative prognosis. A novel exon-6-skipped GALNT14 mRNA variant was identified in patients carrying the rs9679162-TT genotype, which was associated with lower GALNT14 expression and favorable prognosis. Cell-based experiments showed that elevated levels of GALNT14 promoted HCC growth, migration, and resistance to anticancer drugs. Using a comparative lectin-capture glycoproteomic approach, PHB2 was identified as a substrate for GALNT14-mediated O-glycosylation. Site-directed mutagenesis experiments revealed that serine-161 (Ser161) was the O-glycosylation site. Further analysis showed that O-glycosylation of PHB2-Ser161 was required for the GALNT14-mediated growth-promoting phenotype. O-glycosylation of PHB2 was positively correlated with GALNT14 expression in HCC, resulting in increased interaction between PHB2 and IGFBP6, which in turn led to the activation of IGF1R-mediated signaling. In conclusion, the GALNT14-rs9679162 genotype was associated with differential expression levels of GALNT14 and the generation of a novel exon-6-skipped GALNT14 mRNA variant, which was associated with a favorable prognosis in HCC. The GALNT14/PHB2/IGF1R cascade modulated the growth, migration, and anticancer drug resistance of HCC cells, thereby opening the possibility of identifying new therapeutic targets against HCC.https://doi.org/10.1038/s41419-022-05419-y
spellingShingle Yu-De Chu
Tan-Chi Fan
Ming-Wei Lai
Chau-Ting Yeh
GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
Cell Death and Disease
title GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
title_full GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
title_fullStr GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
title_full_unstemmed GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
title_short GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
title_sort galnt14 mediated o glycosylation on phb2 serine 161 enhances cell growth migration and drug resistance by activating igf1r cascade in hepatoma cells
url https://doi.org/10.1038/s41419-022-05419-y
work_keys_str_mv AT yudechu galnt14mediatedoglycosylationonphb2serine161enhancescellgrowthmigrationanddrugresistancebyactivatingigf1rcascadeinhepatomacells
AT tanchifan galnt14mediatedoglycosylationonphb2serine161enhancescellgrowthmigrationanddrugresistancebyactivatingigf1rcascadeinhepatomacells
AT mingweilai galnt14mediatedoglycosylationonphb2serine161enhancescellgrowthmigrationanddrugresistancebyactivatingigf1rcascadeinhepatomacells
AT chautingyeh galnt14mediatedoglycosylationonphb2serine161enhancescellgrowthmigrationanddrugresistancebyactivatingigf1rcascadeinhepatomacells